
Kryzen Biotech Private Limited
About Kryzen Biotech Private Limited
Data last updated:
Kryzen Biotech Private Limited is a private limited company based in Satara, Maharashtra, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 21 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U01100PN2019PTC186207. Its GSTIN is 27AAHCK7659R1ZF (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sudhir Ramesh Devkar and Rajendra Prasad Chaudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 98 Degaon Taluka Wai, Satara, Maharashtra, India – 412803.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.9 Cr, a growth of 131% compared to the previous year. For the same year it recorded a net profit of ₹8.03 Lakh (net margin 2.8%) and EBITDA of ₹12.71 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 430% over three years.
The company is associated with 1 brand: Kryzen Biotech. The company has 1 deal on record (1 funding round), with disclosed funding of ₹75 Lakh; the latest was in March 2024.
Company details
Recognitions & Rankings of Kryzen Biotech
Contact details
Kryzen Biotech Private Limited's registered office is in Satara, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 98 Degaon Taluka Wai, Satara, Maharashtra, India – 412803
- IndustryLife Sciences, Biotechnology
To see the full contact details of Kryzen Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Kryzen Biotech operates one associated brand: Kryzen Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures polyhouses and provides services for hi-tech agriculture in India. | kryzen.com |
Business activity
The main business activities of Kryzen Biotech are construction, agriculture, forestry, fishing and education. In detail, this covers demolition & site preparation, electrical, plumbing & other specialized construction activities, support activities to agriculture and other activities including hunting and higher education, technical & vocational education. 3 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| F | Construction | F3 | Demolition & site preparation, Electrical, plumbing & other Specialized construction Activities | |
| A | Agriculture, forestry, fishing | A4 | Support activities to agriculture and Other Activities including hunting | |
| P | Education | P2 | Higher education, technical & vocational education |
To see the full business activity and turnover split of Kryzen Biotech Private Limited, buy the company report.
Financials of Kryzen Biotech Private Limited
FY 2025 filings availableKryzen Biotech Private Limited reported revenue of ₹2.9 Cr (up 131% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 430% over three years, including 131% growth in the latest year. EBITDA rose 207% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kryzen Biotech Private Limited, buy the company report.
Board of directors of Kryzen Biotech Private Limited
Kryzen Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Ramesh Devkar | Director | 02 Jan 2024 | 2 Years 10 Months | Current |
| Rajendra Prasad Chaudhary Also directs: Webstream.Io Software Private Limited | Director | 06 Sep 2023 | 3 Years 1 Months | Current |
Auditor
Kryzen Biotech Private Limited is audited by AKHIL AMIT AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AKHIL AMIT AND ASSOCIATES | FY 2023 | 155183W |
Shareholding
The shareholding of Kryzen Biotech Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Kryzen Biotech Private Limited, buy the company report.
Deals & funding
Kryzen Biotech Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹75 Lakh; the latest was in March 2024.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Funding round | ₹75 Lakh | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Kryzen Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kryzen Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kryzen Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCK7659R1ZF | Maharashtra | Active | 17 Sep 2019 |
To see the full GST registrations and return filing status of Kryzen Biotech Private Limited, buy the company report.
Recent activity
Kryzen Biotech Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Rajesh Kumar Singh ceased to be Director on 05 Jan 2024.
Frequently asked questions
Kryzen Biotech is an active private limited company based in Satara, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 21 August 2019 (7+ years old) and is registered under CIN U01100PN2019PTC186207.
Kryzen Biotech has 2 current directors:
- Sudhir Ramesh Devkar - Director
- Rajendra Prasad Chaudhary - Director
The latest financial statements of Kryzen Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Kryzen Biotech is 27AAHCK7659R1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kryzen Biotech is U01100PN2019PTC186207. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kryzen Biotech was incorporated on 21 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Kryzen Biotech has 1 deal on record (1 funding round), with disclosed funding of ₹75 Lakh; the latest was in March 2024.
Rajesh Kumar Singh ceased to be Director on 05 Jan 2024. Sudhir Ramesh Devkar was appointed as Director on 02 Jan 2024. Rajendra Prasad Chaudhary was appointed as Director on 06 Sep 2023. Kryzen Biotech has 6 board changes on record in total.
Yes, Kryzen Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Kryzen Biotech is at Plot No 98 Degaon Taluka Wai, Satara, Maharashtra, India – 412803.

